RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$327M
AUM Growth
-$10.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$7.18M
2
+$6.87M
3
+$6.41M
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$4.4M
5
ALKS icon
Alkermes
ALKS
+$4.2M

Top Sells

1
+$11.5M
2
+$8.22M
3
+$7.28M
4
BIIB icon
Biogen
BIIB
+$6.95M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.58M

Sector Composition

1 Healthcare 82.32%
2 Financials 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$1.86M 0.55%
64,000
-7,000
77
$1.84M 0.54%
212,000
-15,000
78
$1.83M 0.54%
62,517
-4,809
79
$1.79M 0.52%
9,200
-4,067
80
$1.78M 0.52%
85,000
+25,000
81
$1.76M 0.51%
122,835
82
$1.7M 0.5%
21,000
+6,000
83
$1.61M 0.47%
+10,000
84
$1.48M 0.43%
55,000
85
$1.44M 0.42%
958
86
$1.35M 0.4%
379,199
+50,000
87
$1.02M 0.3%
+13,030
88
$932K 0.27%
108,535
89
$768K 0.22%
50,000
+12,500
90
$765K 0.22%
500,000
+200,000
91
$623K 0.18%
10,000
-18,500
92
$470K 0.14%
44,221
93
$439K 0.13%
737
94
$416K 0.12%
42,115
95
$328K 0.1%
72,535
96
$300K 0.09%
49,297
97
– –
-10,047
98
– –
-22,500
99
– –
0
100
– –
-80,000
1 2 3
4
5